Efficacy and safety of ramucirumabcontaining chemotherapy in patients with pretreated metastatic gastric neuroendocrine carcinoma

Abstract Background Ramucirumab (RAM), a monoclonal antibody for vascular endothelial growth factor 2 (VEGFR2), has been effective for advanced gastric adenocarcinoma (AC). However, little is known about the efficacy of…

Continue ReadingEfficacy and safety of ramucirumabcontaining chemotherapy in patients with pretreated metastatic gastric neuroendocrine carcinoma

Hybrid Model Integrating Immunohistochemistry andExpression Profiling for the Classification ofCarcinomas of Unknown Primary Site

Identification of the site of origin for ‘malignancy with unknown primary’ remains a challenge for modern pathology. Correct diagnosis is critical to defining the most beneficial treatment for the patient.…

Continue ReadingHybrid Model Integrating Immunohistochemistry andExpression Profiling for the Classification ofCarcinomas of Unknown Primary Site

Clinicopathologic analysis of primary gastroenteropancreaticpoorly differentiated neuroendocrine carcinoma; A ten year retrospective study of 68 cases at Moffit Cancer Center

Abstract Objective: To assess clinicopathological characteristics of primary gastro-entero-pancreatic poorlydifferentiated neuroendocrine carcinomas (GEP-PDNECAs) and evaluate overall survival in patients treatedwith systemic platinum and etoposide therapy.Methods: A detailed retrospective review of…

Continue ReadingClinicopathologic analysis of primary gastroenteropancreaticpoorly differentiated neuroendocrine carcinoma; A ten year retrospective study of 68 cases at Moffit Cancer Center

NEUROENDOCRINE TUMORS: REVIEW OF PATHOLOGY, MOLECULAR AND THERAPEUTIC ADVANCES

Editors: Aejaz Nasir, Domenico CoppolaPublisher: Springer-Verlag, New YorkLanguage: EnglishYear: 2016eBook ISBN: 978-1-4939-3426-3Hardcover ISBN: 978-1-4939-3424-9No. of pages: XIII, 543 The first edition of “Neuroendocrine Tumors: Review of Pathology, Molecular and Therapeutic…

Continue ReadingNEUROENDOCRINE TUMORS: REVIEW OF PATHOLOGY, MOLECULAR AND THERAPEUTIC ADVANCES

Tumor Cell Expression of Vascular Endothelial Growth Factor Receptor 2 Is an Adverse Prognostic Factor in Patients with Squamous Cell Carcinoma of the Lung

Abstract A robust immunohistochemical (IHC) assay for VEGFR2 was developed to investigate its utility for patient tailoring in clinical trials. The sensitivity, specificity, and selectivity of the IHC assay were…

Continue ReadingTumor Cell Expression of Vascular Endothelial Growth Factor Receptor 2 Is an Adverse Prognostic Factor in Patients with Squamous Cell Carcinoma of the Lung

Pre‑test and Post‑test Resuscitation Assessment among Healthcare Workers at Dubai Health Authority

Abstract Background: Understanding the concept of resuscitation is extremely important in the professional life of all healthcare workers. By achieving the appropriate resuscitation knowledge and psychomotor skills, the efficacy of…

Continue ReadingPre‑test and Post‑test Resuscitation Assessment among Healthcare Workers at Dubai Health Authority